UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 8, 2011
Legacy Reserves LP
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
(State or other jurisdiction of
incorporation)
|
|
1-33249
(Commission File Number)
|
|
16-1751069
(I.R.S. Employer Identification No.) |
|
|
|
303 W. Wall, Suite 1400
Midland, Texas
(Address of principal executive offices)
|
|
79701
(Zip Code) |
Registrants telephone number, including area code: (432) 689-5200
NOT APPLICABLE
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
TABLE OF CONTENTS
Item 1.01. Entry into a Material Definitive Agreement.
On November 8, 2011, Legacy Reserves LP (the Partnership), Legacy Reserves GP, LLC, the general
partner of the Partnership, and Legacy Reserves Operating GP LLC and Legacy Reserves Operating LP,
each a wholly owned subsidiary of the Partnership, entered into an underwriting agreement (the
Underwriting Agreement) with UBS Securities LLC, Raymond James & Associates, Inc. and Citigroup
Global Markets Inc. as representatives of the several underwriters named therein (collectively, the
Underwriters), pursuant to which the Partnership sold 3,400,000 units representing limited
partner interests in the Partnership (the Units) at a price to public of $28.850 per Unit
($27.696 per Unit to the Partnership, net of underwriting discount). Pursuant to the Underwriting
Agreement, the Partnership granted the Underwriters a 30-day option to purchase up to an additional
510,000 Units on the same terms and conditions as those Units sold by the Partnership. Closing of
the issuance and sale of the Units is scheduled for November 14, 2011.
The offering of the Units has been registered under the Securities Act of 1933, as amended (the
Securities Act), pursuant to an effective registration statement on Form S-3 (Registration No.
333-174434) of the Partnership (the Registration Statement), and the prospectus supplement dated
November 8, 2011, filed with the Securities and Exchange Commission pursuant to Rule 424(b) of the
Securities Act. Certain legal opinions related to the Registration Statement are filed herewith as
Exhibits 5.1 and 8.1.
The Underwriting Agreement provides that the obligations of the Underwriters to purchase the Units
are subject to approval of certain legal matters by counsel to the Underwriters and other customary
conditions. The Partnership has agreed to indemnify the Underwriters against certain liabilities,
including liabilities under the Securities Act, or to contribute to payments the Underwriters may
be required to make because of any of the those liabilities.
The summary of the Underwriting Agreement in this report does not purport to be complete and is
qualified by reference to such agreement, which is filed as Exhibit 1.1 hereto.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
|
|
|
Exhibit Number |
|
Description |
Exhibit 1.1
|
|
Underwriting Agreement dated November 8, 2011. |
|
|
|
Exhibit 5.1
|
|
Opinion of Andrews Kurth LLP. |
|
|
|
Exhibit 8.1
|
|
Opinion of Andrews Kurth LLP relating to tax matters. |
|
|
|
Exhibit 23.1
|
|
Consents of Andrews Kurth LLP (included in Exhibits 5.1 and 8.1). |
1